Skip to content
FIND A BIOALPS ACTOR

Actor

Eclosion2 & cie SCPC

Share this actor

Life science investment fund focusing on translating cutting edge science into biotechnology companies developing transformational best-in-diseases therapeutics and platform technologies.
Eclosion2 fund’s portfolio companies have developed first-in-class drugs with high potential value to patients in fields such as multiple sclerosis, fibrosis or oncology.
Eclosion private investment fund supports portfolio companies from seed to capital stage up to clinical proof of concept, making significant long term operational and financial commitments to companies that have the potential to change the way patients are treated.

Specialties

Primary Therapeutic Areas

Business model

5. Venture Capital & Investment

5.5 Public & Philantropic VC

Organization Type

Private Company


Visit website

Domains

Endocrine & Metabolic, Neurology, Oncology, Respiratory

Main sector

Public & Non-Profit Organism

Contact

Avenue de Sécheron 15
1202 Geneva / GE

info@eclosion.com